Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-09-19
2006-09-19
Shukla, Ram R. (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000
Reexamination Certificate
active
07109317
ABSTRACT:
Materials and methods are disclosed for regulation of biological events such as target gene transcription and growth, proliferation or differentiation of engineered cells.
REFERENCES:
patent: 5830462 (1998-11-01), Crabtree et al.
patent: 6165787 (2000-12-01), Crabtree et al.
patent: 0 618 227 (1994-10-01), None
patent: WO 94 18317 (1994-08-01), None
patent: WO 96 12806 (1996-05-01), None
patent: WO 96 16172 (1996-05-01), None
patent: WO 96/41865 (1996-12-01), None
patent: WO 97 06246 (1997-02-01), None
B Chaudhuri et al.,Biochemical and Biophysical Research Communications, “Only in the Presence of Immunophilins can Cyclosporin . . . Autoinhibitory domain yet strengthen interaction between Calcineurin A and B Subunits,”Oct. 1995, vol. 215, No. 2, 781-790.
D Guerini et al.,Proc.Natl.Acad. Sci USA “Cloning of human calcineurin A: Evidence for two isozymes and identification of a polyproline structural domain,”Dec. 1989, vol. 86, pp. 9183-9187.
Mondragon A, Overexpression and purification of human calcineurin alpha fromEscherichia coliand assessment of catalytic functions of residues surrounding the binuclear metal center, 1997, Biochemistry, 36, 4934-42.
Li R, Materials for immunoisolated cell transplantation, 1998, advanced drug delivery reviews, 33, 87-109.
Deonarain M, Ligand-targeted receptor-mediated vectors for gene delivery, 1998, Expert Opinion on Therapeutic Patents, 8(1), 53-69.
Wall RJ, Transgenic livestock: progress and prospects for the future, 1996, Theriogenology, 45, 57-68.
Houdebine LM, Production of pharmaceutical proteins from transgenic animals, 1994, J. of Biotechnology, 34, 269-87.
Hammer RE, Genetic engineering of mammalian embryos, 1986, J. of Animal Science, 63, 269-78.
Mullins LJ, Transgenesis in the rat and larger mammals, 1996, J. Clin Invest., 97(7), 1557-60.
Verma IM, Gene therapy-promises, problems, and prospects, 1997, Nature, 389, 239-42.
Miller N, Targeted vectors for gene therapy, 1995, FASEB, 9, 190-99.
Sigmund CD, Viewpoint: are studies of genetically altered mice out of control?, 2000, Aterioscler Thromb Vasc Biol., 20, 1425-29.
Cameron ER, Recent advances in transgenic technology, 1997, Mol Biotechnol, vol. 7 (3), 253-65.
Niemann II, Transgenic farm animals get off the ground, Transgenic Res., 1998, 7(1), 73-5.
Crystal RG, Transfer of genes to humans: early lessons and obstacles to success, 1995, Science 270, 404-10.
Anderson FW, Human gene therapy, 1998, Nature, 392, 25-30.
Kappel C.A. et al. Regulating Gene Expression in Transgenic Animals. Current Opinion Biotech. 1992, vol. 3, pp. 548-553.
Houdebine LM, The methods to generate transgenic animals and to control transgene expression, 2002, J. of Biotechnology, vol. 98, pp. 145-160.
Ristevski S, Making better transgenic models, 2005, Molecular Biotechnology, vol. 29, pp. 153-163.
Smith KR, Gene transfer in higher animals: theoretical considerations and key concepts, J. of Biotechnology, vol. 99, pp. 1-22.
Montoliu L, Gene transfer strategies in animal transgenesis, 2002, Cloning and Stem Cells, vol. 4, pp. 39-46.
Griffith et al., (1995). Cell 82:507-522.
Braun et al., (1995) FASEB J., 9:63-72.
Bierer et al., (1993) Current Opinion in Immunology 5:763-773.
Alberg and Schreiber (1993) Science 262:248-250.
Clipstone et al., (1994) J. Biol. Chem 269:26431-26437.
Sigal and Dumont (1992) Ann. Rev. Immunol. 10:519-560.
Pruschy et al., (1994) Chemistry and Biology 1:163-172.
Bram et al., (1993) Mol Cell Biol 13:4760-4769.
Liu et al., (1991) Cell 66:807-815.
Belshaw et al., (1996) Chemistry and Biology 3:731-738.
Kennedy, M.T., et al. “Contributions of Myristoylation to Calcineurin Structure/Function”, J. Biol. Chem., vol. 271, No. 43, Oct. 25, 1996, pp. 26517-26521.
Wei, Q. and Lee, E.Y. “Expression and reconstitution of calcineurin A and B subunits”, Biochem. Mol. Biol. Int., vol. 41, No. 1, Jan. 1997, pp. 169-177.
Clemons Paul A.
Gladstone Brian G.
Schreiber Stuart L.
Seth Abhinav
Fish & Neave IP Group Ropes & Gray LLP
Montanari David A.
President and Fellows of Harvard College
Shukla Ram R.
LandOfFree
FK506-based regulation of biological events does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FK506-based regulation of biological events, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FK506-based regulation of biological events will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3605685